Related Experiment Video
Updated: Feb 11, 2026

In Vitro Rearing of Solitary Bees: A Tool for Assessing Larval Risk Factors
Published on: July 16, 2018
Nephrolithiasis and Nephrocalcinosis in Childhood-Risk Factor-Related Current and Future Treatment Options
Alexander Weigert1, Bernd Hoppe1
1Division of Pediatric Nephrology, Department of Pediatrics, University Children's Hospital, Bonn, Germany.
Insights
Pediatric nephrolithiasis and nephrocalcinosis often stem from metabolic issues, necessitating prompt diagnosis. Current treatments are limited, but future therapies show promise for kidney stone disease.
Area of Science:
- Pediatric Nephrology
- Metabolic Disorders
- Urology
Background:
- Nephrolithiasis, urolithiasis, and nephrocalcinosis are frequent reasons for pediatric hospitalizations.
- Early diagnostic evaluation is crucial as metabolic causes are found in approximately 80% of children with kidney stones.
- Current therapeutic strategies for pediatric kidney stone disease are limited.
Purpose of the Study:
- To review current treatment options for pediatric nephrolithiasis, urolithiasis, and nephrocalcinosis based on identified lithogenic risk factors.
- To provide an outlook on potential future therapeutic strategies for these conditions in children.
Main Methods:
- This is a review article.
- Summarizes current and potential future treatment options for pediatric kidney stone disease.
- Focuses on treatments tailored to specific lithogenic risk factors.
Main Results:
- Metabolic abnormalities are identified in a high percentage of pediatric patients with kidney stone disease.
- Existing treatments primarily involve general measures like increased fluid intake or enhancing lithogenic substance solubility.
- Specific treatments are available based on identified risk factors.
Conclusions:
- Early diagnosis and metabolic evaluation are critical for managing pediatric kidney stone disease.
- Current treatment options are limited, emphasizing the need for further research and development.
- Innovative therapies, including mRNA-based and recombinant enzyme substitution, represent promising future directions.
Abstract:
Nephrolithiasis, urolithiasis, and nephrocalcinosis (NC) have become common causes of hospitalization and referral to pediatric outpatient clinics. It is of utmost importance to start with diagnostic evaluation directly after the first passage of a kidney stone, or if NC is diagnosed, in each pediatric patient. This is necessary, as in about 80% of children a metabolic reason for stone disease is detected. Current treatment options are scarce and mainly include general measures like an increased fluid intake or elevating the solubility of a lithogenic substance. According to the given lithogenic risk factor(s), specific treatment options are available and are being summarized in this review. Furthermore, an outlook on potential future treatment options, including innovative strategies such as mRNA-based or recombinant enzyme substitution therapy, is given.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Relative Risk
Erikson's Theory on Socioemotional Development during Childhood
The first four of Erikson's eight...
Transcription Factors
Electrical Current
Piaget's Theory of Cognitive Development from Childhood into Adulthood
Schemata: Building Blocks of Knowledge

